Focal cortical dysplasia type IIb is characterized by epilepsyassociated malformations that are often composed of balloon cells and dysplastic neurons. There are many histopathologic similarities between focal cortical dysplasia type IIb and cortical tubers in tuberous sclerosis complex (TSC), an autosomal-dominant phakomatosis caused by mutations in the TSC1 or TSC2 genes that encode hamartin and tuberin. We previously found that an allelic variant of TSC1 (hamartin H732Y ) is increased in focal cortical dysplasia type IIb. Here, we investigated the subcellular localization of hamartin H732Y and its interaction with tuberin in vitro. Coimmunoprecipitation assays with tuberin revealed reduced tuberin binding of hamartin H732Y compared with wild-type hamartin. Tuberin binding was also reduced for 2 TSC1 stop mutants (hamartin R692X and hamartin
INTRODUCTION
Tuberous sclerosis complex (TSC) is an autosomaldominant multiorgan disorder characterized by benign tumors and dysplastic lesions in many organs, including skin, kidney, lungs, heart, and brain (1, 2) . Cerebral cortical tubers are frequently composed of large dysmorphic neurons and giant cells. Cortical dysplasias associated with focal epilepsies consist of dysplastic cytomegalic neurons and balloon cells (focal cortical dysplasia type IIb [FCD IIb ] according to the so-called Palmini classification [3] ; Fig. 1 ). Thus, they resemble cortical tubers. Patients with FCD IIb generally lack additional features of a neurocutaneous phakomatosis (4) .
Tuberous sclerosis complex is caused by mutations in TSC1 on chromosome 9q34 (5) or TSC2 on chromosome 16p13.3 (6, 7) . Remarkably, TSC1/TSC2 mutations are only detected in approximately 85% of TSC patients (8) . Hamartin and tuberin, the corresponding gene products, form a heterodimer operating as a tumor suppressor in the phosphatidylinositol 3-kinase pathway (5, 9, 10) . Consistent with the Knudson 2-hit hypothesis, extracerebral neoplasms in TSC patients frequently harbor loss of heterozygosity (11) . In contrast, loss of heterozygosity has been rarely found in TSC brain lesions (12) .
Recent data suggest that the TSC pathway in neurons is highly sensitive to gene dosage effects, including the observation that TSC1 haploinsufficiency impairs neuronal morphology (13) . Furthermore, only little is known about a potentially impaired subcellular distribution of TSC1 sequence variants, that is, aberrant nuclear localization of hamartin in a tuber was demonstrated in a case study (14) . It has also been shown that oligomerization of the hamartin carboxyl-terminal coiled coil domain was inhibited in the presence of tuberin (15) . The presence of hamartin aggregates in FCD IIb components (Fig. 1 ) may suggest that aberrant interactions between hamartin and tuberin also occur in these epilepsy-associated lesions.
Here, we used in vitro approaches to analyze whether TSC1 coding allele variants in the predicted tuberin-binding domain of hamartin (5) impair this interaction and lead to aberrant subcellular distribution of the resulting hamartin protein variants. Therefore, we focused on the allelic variant known to be increased in FCD IIb patients, that is, a base exchange from C to G in exon 17 of TSC1 at nucleotide 2415 that results in an amino acid exchange from the basic histidine to the neutral tyrosine at codon 732 (hamartin H732Y [16] ). This variant is also present at lower frequencies in TSC patients and unaffected individuals (17Y19). We also analyzed hamartin R692X and hamartin R786X , that is, truncations in the hamartin-tuberin interaction domain that are frequently observed in TSC-associated cortical tubers (18Y20). Our data suggest strikingly impaired tuberin binding as well as divergent subcellular distribution patterns of these hamartin variants and provide novel insights into their pathogenetic role in FCD and TSC.
MATERIALS AND METHODS

Surgical Specimens and Immunohistochemistry
Tissue specimens were obtained from FCD IIb (n = 12 patients), cortical tubers (n = 2 patients), and subependymal giant cell astrocytomas (SEGAs, n = 3 patients) (Table) . Biopsy samples were collected from patients with chronic pharmacoresistent focal epilepsies in the Epilepsy Surgery Program at the University of Bonn. One patient with SEGA did not have epilepsy. In all epileptic patients (n = 16), surgical removal of the lesion was necessary to achieve seizure control after presurgical evaluation, as previously described (21) . Only patients with cortical tubers and SEGAs had additional features characteristic of TSC (5, 8) . In a patient with a SEGA (ID 17), neurosurgical intervention was carried out under tumor-surgical considerations. The clinical characteristics of the patients are summarized in the Table. Written informed consent was obtained from all patients concerning the use of brain tissue. All procedures were conducted in accordance with the Declaration of Helsinki and approved by the ethics committee of the University of Bonn Medical Center. Surgical specimens were fixed in formaldehyde overnight and embedded in paraffin. The FCD IIb specimens were reviewed by experienced neuropathologists and classified according to international classification schemes (3). Hematoxylin and eosin (H&E) and NisslYLuxol fast blue stains and immunohistochemistry with antibodies against vimentin and neurofilament protein were carried out according to standard procedures (22) . Immunohistochemical staining of hamartin in paraffin sections was performed using a monoclonal antibody (Cell Signaling, Frankfurt, Germany; Clone 1B2, diluted 1:200) according standard procedures (22) . Negative control reactions replacing the primary specific antibody by nonspecific immunoglobulin were performed to assure specific binding affinity (data not shown).
Generation of Plasmid Constructs
To generate pmCherry-TSC1, we first amplified the human TSC1 cDNA coding sequence from pcDNA3.1mycA-TSC1 and subcloned the amplicon into the pCDNA3.1 V5 HIS TOPO vector (Invitrogen, Munich, Germany) using the primer pair TSC1 forward (5 ¶-GCG GCT AGC ATG GCC  CAA CAA GCA AAT G-3 ¶) and TSC1 reverse (5 ¶-GCG  GGT ACC TTA GCT GTG TTC ATG AGT CTC-3 ¶) . Subsequently, an mCherry tag was inserted N-terminally in pcDNA3.1-TSC1 to generate pmCherry-TSC1. Therefore, mCherry was amplified from the pBKS-mCherry plasmid (a generous gift from Dr T. Südhof, Stanford, CA) using the primer pair mCherry forward (5 ¶-GCG TCT AGA ACC ATG GTG AGC AAG GGC GA-3 ¶) and mCherry reverse (5 ¶-GCG GCT AGC CTT GTA CAG CTC GTC CAT GCC-3 ¶). The resulting polymerase chain reaction product was digested with NheI and XbaI (Fermentas, Burlington, Canada) and pCDNA3.1-TSC1 with NheI. DNA sequencing was performed to verify that all sequences were correct (BigDye Terminator v3.1 Cycle Sequencing Kit; Applied Biosystems, Foster City, CA). Truncated and mutated hamartin proteins were generated by site-directed mutagenesis of the pCDNAmcherry-TSC1 plasmids (QuickChange II SiteYdirected mutagenesis kit, Stratagene, Cedar Creek, TX) following the manufacturer's manual with the following primers: TSC1 R786X forward: 5 ¶-CAG ATC AGA CAG CTA CAG CAT GAC TGA GAG GAG TTC TAC-3 ¶; TSC1 R786X reverse: 5 ¶-GTA GAA TTC CTC TCA GTC ATG CTG TAG CTG TCT GAT CTG-3 ¶. By base exchange from C to T in codon 786 of TSC1, a stop codon is created, resulting in a truncated TSC1 protein. For rapid screening of mutant clones, a silent base exchange from G to A was generated, which resulted in the deletion of a PstI restriction site (CTGCA/G). For another truncated TSC1 variant, we used the primers: TSC1 R692X forward: 5 ¶-GAT GAG ATC CGC ACC CTC TGA GAC CAG CTG CTT TTA CTG CAC AAC-3 ¶; TSC1 R692X reverse: 5 ¶-GTT GTG CAG TAA AAG CAG CTG GTC TCA GAG GGT GCG GAT CTC ATC-3 ¶. The base exchange from C to T creates a stop codon at position 692 of TSC1, whereas the silent mutation from T to C resulted in the creation of a new PvuII restriction site (CAG/CTG). We further used the primers: TSC1 H732Y forward: 5 ¶-GTG ATC AAA GCA GCA GCT CTC GAG GAA TAT AAT GCT GCC ATG-3 ¶; TSC1 H732Y reverse: 5 ¶-CAT GGC AGC ATT ATA TTC CTC GAG AGC TGC TGC TTT GAT CAC-3 ¶. This base exchange from C to T results in an amino acid exchange from histidine to tyrosine, screened by the detection of an additional restriction site of XhoI (C/TCGAG) generated by a silent base exchange from G to C. Mutagenesis was verified by restriction digest and sequencing.
Cell Culture and Transfection Procedures
HEK293T cells were cultured in Dulbecco modified Eagle medium (Invitrogen, Carlsbad, CA) supplemented with 10% fetal calf serum and 1% penicillin/streptomycin at 37-C in 5% carbon dioxide. Transfection of HEK293T cells was performed using Lipofectamine 2000 (Invitrogen) following the manufacturer's protocol.
Colocalization Assay
HEK293T cells were cultured on coverslips and transfected with TSC2-enhanced green fluorescence protein and the different mCherry-TSC1 expression plasmids, at a confluence of approximately 25%, as previously described. After 48 hours, cells were fixed in 4% paraformaldehyde and analyzed by confocal fluorescence microscopy (Olympus, Munich, Germany). Micrographs were examined using a colocalization assay plug-in on ImageJ.
Western Blot Analysis
For Western blot experiments, HEKT293 cells were transfected with the mCherry-TSC1 plasmid at about 80% confluence and cultured for 2 more days. Cell pellets were resuspended in PBS and 6Â loading dye (4Â Tris-Cl/sodium dodecyl sulfate [SDS] pH 6.8, 30% glycerol, 10% SDS, 5%-mercaptoethanol, 0.012% bromphenol blue) and then lysed by sonification. Equal amounts of cell lysate were separated by electrophoresis on an 8% SDSYpolyacrylamide gel and transferred to nitrocellulose membranes (Protran Whatman, Kent, UK) overnight at 4-C. After blocking the membrane for 1 hour with PBS/1% cold water fish gelatin (SigmaAldrich, St Louis, MO), it was incubated overnight with a monoclonal hamartin antibody (dilution 1:1000) (Hamartin 1B2 Mouse mAB, Cell Signaling, Boston, MA) in PBS, 0.1% TWEEN. IrDye fluorescent secondary antibodies (LI-COR, Lincoln, NE) were diluted 1:20,000 in PBS, 0.1% TWEEN, 0.01% SDS, and incubated for 1 hour. Immunoblots were visualized using the LI-COR Odyssey system (LI-COR).
Immunoprecipitation Assays
For immunoprecipitation analyses, HEK293T cells were harvested 2 days after cotransfection with the various cherry-tagged TSC1 expression plasmids and the green fluorescence protein-tagged TSC2 expression plasmid. Cell pellets were resuspended in lysis buffer (150 mmol/L NaCl, 40 mmol/L Tris-HCl pH 7.4, 1 mmol/L EDTA, 0.5% Nonidet P-40, 1 mmol/L phenylmethanesulfonyl fluoride, protease inhibitor cocktail; Roche, Indianapolis, IN) and incubated for 1 hour at 4-C. Meanwhile, 30 KL of protein A/G plus agarose (Santa Cruz Biotechnology, Santa Cruz, CA) slurry were conjugated with 1 Kg of an antibody against hamartin (sc-12082) or tuberin (sc-893) (both from Santa Cruz Biotechnology) in 500 KL lysis buffer at 4-C. After centrifugation of the cell lysate for 10 minutes at 14,000 rpm at 4-C, the supernatant was precleared with 50 KL of protein A/G plus agarose slurry and 1 Kg of normal mouse IgG (Santa Cruz Biotechnology) for 1 hour at 4-C. Subsequently, the lysate was added to the conjugated primary antibodies and incubated for 2 hours, rotating at 4-C. The immunoprecipitated complexes were washed 5 times with lysis buffer and analyzed by electrophoresis on a 6% SDS polyacrylamide gel followed by immunoblotting, as previously described.
Immunocytochemistry and Phase-Contrast Microscopy
For immunofluorescence analysis, HEK293T cells were cultured on coverslips for 2 days after transfection and then fixed in 4% paraformaldehyde for 15 minutes at room temperature. After 3 rounds of washing with ice-cold PBS, cells were permeabilized with 0.1% Triton X-100/PBS for 15 minutes and then blocked for 1 hour at room temperature (blocking buffer: 10% normal goat serum, 1% bovine serum albumin in PBS). Cells were incubated overnight with primary antibodies anti-LAMP1 and anti-ERGIC-53/p58 (Sigma-Aldrich) at 4-C and diluted in blocking buffer to a concentration of 1:200. After washing with PBS, secondary antibody was added in a dilution of 1:400 in blocking buffer for 1 hour. The labeling was analyzed by confocal fluorescence microscopy as previously described. Cultured cells were photographed by phase-contrast microscopy (Observer A1; Zeiss, Jena, Germany) in the culture plate.
Statistical Analysis
Two-sided Student t-test was used for statistical analysis of the data.
RESULTS
We have observed that the lesions of FCD IIb , that is, common epilepsy-associated malformations that resemble cortical tubers in TSC (Figs. 1AYD, IYK) , show strikingly aberrant cytoplasmic granular aggregation of hamartin in balloon cells and in dysmorphic neurons (Figs. 1E, F) . By contrast, regularly shaped neurons in normal cerebral cortex have a homogeneous cytoplasmic distribution of hamartin (Figs. 1G, H) . Moreover, aberrant hamartin aggregation in FCD IIb is also observed in dysmorphic neuronal and giant cell elements of cortical tubers (Figs. 1L) and in highly differentiated subependymal SEGAs (Figs. 1MYP) . Both cortical tubers and SEGAs are frequently associated with TSC. These observations prompted us to determine whether sequence variants of TSC1 that are frequent in FCD IIb and TSC-associated brain lesions are associated with aberrant subcellular distribution or impaired tuberin binding of the resulting hamartin variants. Because numerous components of the phosphatidylinositol 3-kinase cascade operate abnormally in FCD IIb and cortical tubers (23), we used a highly controlled in vitro approach for this analysis.
We first generated various plasmids that express TSC1 fused to the fluorescent reporter mCherry. In addition to wild-type (WT) TSC1, we derived TSC1 constructs carrying the amino acid exchanges H732Y, R786X, and R692X (Fig. 2) . Mutations in codons 786 and 692 result in truncated hamartin variants that are frequently detected in TSC patients (18Y20) and are localized at different sites within the tuberin interaction domain of hamartin (Fig. 2 ). Next, we tested for protein expression and stability of the TSC1 fusion proteins by transfection of HEK293T cells and immunoblotting. HEK293T cells are a widely used cell line for protein interaction experiments. All proteins were expressed at high levels and migrated at the expected calculated molecular weights (Fig. 3) . To assess the binding efficiency of WT and mutant TSC1 proteins to tuberin in vitro, we performed immunoprecipitation experiments from extracts of transiently transfected HEK293T cells using an antibody directed against an epitope present in all mutant hamartin protein variants and then probed the precipitates with an antibody against tuberin. As shown in Figures 4A and B , tuberin was efficiently precipitated when coexpressed with hamartin WT , but there was reduction in tuberin-binding affinity for hamartin R692X . Because this protein variant contains an aberrant stop codon positioned most N-terminal in the tuberin interaction domain, the resulting hamartin product lacks large portions of the coiledcoil domain responsible for tuberin binding (Figs. 4A, B) ; 5.1-fold binding reduction, for hamartin R692X n = 3 replicates, hamartin WT for all n = 9 replicates, t-test, p G 0.05. Correspondingly, the hamartin R786X variant also showed a significantly reduced binding affinity to tuberin (Figs. 4A, B) ; 3.3-fold binding reduction, for hamartin R786X n = 4 replicates, t-test, p G 0.05. In the hamartin R786X protein, however, a larger part of the tuberin binding coiled-coil domain is present than in hamartin R692X . Strikingly, also a hamartin protein variant (hamartin H732Y ), which is found in normal individuals, TSC patients with cortical tubers, as well as in FCD IIb , and in which the tuberin binding domain only exhibits a single amino acid exchange, showed a significant reduction in tuberin binding (Figs. 4A, B) ; 2.3-fold binding reduction, for hamartin H732Y n = 9 replicates, t-test, p G 0.05. Identical results were obtained if the immunoprecipitations were performed vice versa using an antibody against tuberin (data not shown). Together, these experiments show that mutations found in the tuberin-binding domain of hamartin in cortical tubers and in FCD IIb directly affect the interaction of these 2 proteins.
We next characterized the subcellular distribution of the different hamartin protein variants. Hamartin WT showed a cytoplasmic localization mostly concentrated in close vicinity to the cellular membrane (Fig. 5) . The expression pattern of hamartin WT seemed homogeneous. Hamartin R692X and hamartin R768X were more dispersed in the cytoplasm and accumulated in granular-like patterns that are distinct from that of hamartin WT (white arrows, Fig. 5 ). The granular masses of hamartin R692X and hamartin R768X suggest selfaggregation, a phenomenon that has been previously described (15) . Intriguingly, hamartin H732Y revealed a completely different subcellular distribution as it was almost completely localized in the nucleus without any significant cytoplasmic expression. This observation was confirmed by 4 ¶,6-diamidino-2-phenylindole, dihydrochloride (DAPI) staining (Fig. 5) .
We next examined the consequences of the H732Y allelic variant on the interaction of hamartin and tuberin in live cells. We overexpressed both proteins in HEK293T cells Hamartin-cherry variants were immunoprecipitated using a hamartin antibody. Subsequently, immunoblots were probed with an antibody against tuberin. The probes were normalized to the whole lysates. Only the tuberin band of the wild-type (WT) hamartin probe can be detected with certainty. This assay was also performed in the reverse order with identical results (data not shown). (B) To examine the binding efficiency between hamartin, WT, and mutant variants and tuberin in vitro, the amount of tuberin that was immunoprecipitated by the different hamartin variants was quantitated after immunoblotting using AIDA software. All 3 hamartin variants show a substantially decreased binding to tuberin compared with that of hamartin WT . Hamartin WT , n = 9; hamartin H732Y , n = 9; hamartin R786X , n = 4; hamartin R692X , n = 3; t-test, *p e 0.05. Hamartin WT showed cytoplasmic localization mostly concentrated near the cellular membrane. In contrast, the hamartin R786X and hamartin R692X variants were more disseminated throughout the cytoplasm and accumulated in granular aggregates (white arrows). Hamartin H732Y exhibited a completely different subcellular distribution compared with that of the other proteins as it was almost completely transferred to the nucleus. The exclusively nuclear localization of hamartin H732Y was confirmed by colocalization with DAPI staining. Scale bars = 10 Km.
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and analyzed their colocalization pattern by confocal fluorescence microscopy. The data corroborated the observation that hamartin H732Y was translocated to the nucleus even in the presence of increased levels of tuberin. Interestingly, tuberin showed a diffuse cytoplasmic distribution pattern (Fig. 6A) . Using the ImagJ plug-in, we analyzed the colocalization of hamartin and tuberin semiquantitatively and detected significantly reduced colocalization of hamartin H732Y with tuberin compared with that of WT (t-test, p G 0.001; for hamartin H732Y , n = 48 cells counted; for hamartin WT , n = 46 cells counted; for hamartin R786Y , n = 50 cells counted; for hamartin R692X , n = 45 cells counted; Fig. 6B ). Hamartin WT showed colocalization with tuberin in a largely cytoplasmic distribution (Figs. 6A, B) . Interestingly, in these experiments, both truncation mutants exhibited a strong cytoplasmic colocalization with tuberin highly similar FIGURE 7. Analysis of potential colocalization of hamartin in different subcellular compartments. (A) Cells were transfected with various mCherry-hamartin fusion proteins. Immunocytochemistry was performed with anti-LAMP1, which marks lysosomes, and anti-ERGIC-53/p58, which marks endoplasmic reticulum and Golgi apparatus components. These primary antibodies were detected with a green fluorescent secondary antibody. For colocalization of hamartin with mitochondria, HEK293T cells were cotransfected with the hamartin variants fused to mCherry and a plasmid exclusively expressed in mitochondria, pmitoYgreen fluorescence protein (a generous gift from W. Altrock; IFN, Magdeburg, Germany). Results were analyzed by confocal fluorescence microscopy. Hamartin R692X was present in nuclei; the other variants were located in the cytoplasm in different distribution patterns. There was no reproducible or substantial colocalization of hamartin with any of these compartment-specific markers. to the distribution pattern of hamartin WT (Figs. 6A, B) . None of the cotransfected hamartin protein variants resulted in an altered distribution of tuberin in the cells.
We performed further immunocytochemistry of transfected HEK293T cells with probes of proteins localized specifically at the Golgi apparatus, the endoplasmic reticulum and lysosomes, and mitochondria to determine whether the individual hamartin variants had different colocalization patterns within these subcellular compartments (Fig. 7A) . We did not observe distinct or specific colocalization patterns of the individual hamartin protein variants with these compartments, however. Importantly, the distribution patterns of the distinct hamartin variants were independent of the variable morphology of the HEK293T cells (Fig. 7B) . Generally, clustered cells in close contact exhibit a round to ovoid appearance (Figs. 7B1, B3 ). In contrast, individual cells in more isolated localization reveal a rather spindle-like shape (Figs. 7B2, B3 ). The variability of HEK293T cellular shape distribution was independent of transfection of cells with the different TSC1 variants.
DISCUSSION
We observed strikingly aberrant subcellular distribution patterns of hamartin in various epilepsy-and TSC-associated lesions. In contrast to neurons in normal cortex that have diffuse cytoplasmic expression of hamartin FCD IIb , cortical tubers and SEGAs exhibit cytoplasmic granular aggregates of hamartin (Fig. 1) ; these are similar to previously reported findings (24) . Our present in vitro results also reveal striking differences in tuberin binding and subcellular distribution among hamartin variants that are frequently observed in epilepsy-associated cortical dysplasias and cortical tubers (17Y20). Both hamartin variants with a truncated tuberinbinding domain exhibited significantly reduced binding affinity to tuberin. This observation is surprising for hamartin R786X , which still encompasses a substantial part of this domain. Interestingly, hamartin H732Y , an allelic variant of TSC1 present in healthy individuals (17) , is highly abundant in FCD IIb (16) and is present in TSC patients who lack pathogenic TSC1, and TSC2 mutations (18) also showed a substantially reduced ability to interact with tuberin. Indeed, the affinities of hamartin H732Y and hamartin R786X to tuberin were similar (Fig. 3) . This result was rather surprising because 1) in contrast to hamartin H732Y , the hamartin R786X variant has been reported to cause manifest TSC and 2) the hamartin H732Y variant differs from hamartin WT by only a single amino acid exchange from the basic amino acid histidine to the neutral tyrosine within the interaction domain to tuberin. This sequence alteration at codon 732 may alter the 3-dimensional structure of hamartin at the predicted binding domain with tuberin (5) . Aberrant interaction of hamartin H732Y with tuberin is compatible with downstream activation of the phosphatidylinositol 3-kinase cascade recently described in FCD IIb (9, 25, 26) .
An important aspect for understanding the pathophysiological relevance of TSC1 allelic variants relates to potentially aberrant subcellular localization of the corresponding hamartin variants compared with tuberin. Factors such as cell type-specific differences and low abundance or antibody limitations may account for previous findings that hamartin and tuberin are localized to different cellular compartments (10, 15, 27Y29). It has been demonstrated, however, that tuberin and hamartin associate physically in vivo (10, 30); all of these studies provide evidence for a cytosolic tuberin-hamartin complex. Hamartin has been localized to the membrane/particulate (P100) fraction of cultured cells (30, 31) . Recently, nuclear localization of hamartin in pancreatic acinar tissues and individual cell components in the cerebellar granular layer of the cerebellum were also reported (32) .
Because of its subcellular localization, hamartin may transmit information about changes in cell adhesion to the nucleus; its involvement in normal cell death may accompany cell detachment or provide an additional potential indirect mechanism through which the cell cycle could be affected. Indeed, it has been suggested that hamartin is a nuclear shuttling protein that accumulates in the nucleus upon inhibition of nuclear export with leptomycin B, which itself inhibits Exportin 1, a protein required for nuclear export of proteins containing a nuclear export sequence (1). Intriguingly, our finding of hamartin H732Y accumulation in the nucleus (in contrast to hamartin WT , hamartin R786X , and hamartin R692X , which are cytoplasmic) implies the following scenarios for allelic variants in contrast to hamartin WT , which is tightly bound to tuberin in a protein complex. Because of the conserved nuclear localization sequence (BRQQHALRNRR[ sequence at 708 of hamartin), hamartin H732Y has a reduced binding affinity to tuberin and is shuttled into the nucleus. In view of the relevance of hamartin for cell cycle regulation, this aberrant cytoplasmicnuclear shuttling of hamartin disrupts the cycling of affected cells. In contrast, hamartin R786X and hamartin R692X are not transported to the nucleus. Accordingly, hamartin R692X lacks the nuclear localization sequence at 708, whereas for hamartin R786X , another mechanism, such as protein misfolding of the truncated protein, may account for its localization. Aberrant nuclear accumulation of hamartin H732Y might impair cell cycling, although the specific effects of this phenomenon were not addressed by the experimental approaches of the present study. It has been shown, however, that hamartin and tuberin influence the activity of molecules critically involved in cell cycle regulation such as CDK1 (33) . On the other hand, this aberrant protein variant might also perturb regular nuclear functions in a manner similar to what is known for aberrant protein aggregates in neurodegenerative conditions such as spinocerebellar ataxia type 3 (34) . Recent data demonstrated that appropriate phosphorylation, sequestration, and turnover of the TSC protein complex represent critical issues for proper cellular function (35Y37). Particularly, the aberrant cytoplasmic aggregates of hamartin we demonstrated in FCD IIb , cortical tuber and SEGA patient tissues, as well as our in vitro findings for the hamartin stop variants may imply impairment of protein sequestration. However, we did not observe increased association of the hamartin stop variants, such as with lysosomes (Fig. 7) .
The hamartin H732Y allele is also detected in the normal population, with a frequency of 0.5%. Therefore, this sequence alteration cannot be sufficient to cause TSC or FCD. Intriguingly, it has been recently shown that the TSC pathway is sensitive to gene dosage effects, such that loss of a single copy of TSC1, as it is manifest in all neurons of TSC patients, is sufficient to disturb dendritic spine structure (13) . Furthermore, loss of heterozygosity has been shown in FCD IIb components of individuals carrying the hamartin H732Y allele (16) . Our present data suggest that hamartin H732Y may constitute a predisposing germline variant with low penetrance and a strongly restricted manifestation pattern, which only in individual cells (or e.g. restricted neural precursor clones) overcomes a virtual pathological threshold. This concept is compatible with the remarkable notion that surgical resection of FCD IIb is curative with respect to seizure events in most patients (38) , whereas TSC patients with cortical tubers frequently develop secondary seizure foci after removal of epileptogenic tubers/foci.
It was suggested recently that hamartin could have discrete and specialized functions besides its role in the TSC1/TSC2 complex because of its nuclear localization (39) . In line with this idea, hamartin is capable of attenuating the proliferation of mammalian cells (40) . Aberrant cellular accumulation of hamartin allelic variants may therefore account for reduced proliferation and cellular densities in cortical dysplasias (41) and the characteristic enlarged and dysplastic cellular phenotype of FCD IIb elements. Based on these considerations, our data suggest that hamartin, which has mainly been regarded as an interaction partner in the tumor suppressor complex with tuberin, has a pronounced independent functional relevance in the pathogenetic context of TSC and cortical dysplasias.
